Breaking News, Collaborations & Alliances

Mytos & Aspen Partner to Automate Parkinson’s Disease Cell Therapy Manufacturing

Aspen to integrate Mytos’ iDEM automated cell culture technology into its manufacturing facility in Torrey Pines, CA.

Author Image

By: Charlie Sternberg

Associate Editor

Image: Mytos

Mytos has entered into a manufacturing collaboration with Aspen Neuroscience Inc. to automate the manufacturing of autologous dopaminergic neuronal precursor cells (DANPCs) for ANPD001, Aspen’s investigational cell therapy program for Parkinson’s disease (PD). The DANPCs, designed to replace lost dopamine-producing neurons in the brain, are differentiated from induced pluripotent stem cells (iPSCs), which are derived from the patient’s own skin cells. This approach holds the promise of restor...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters